Reps. Pressley, Maloney Applaud FDA's Review of Restrictions Preventing Access to Mifepristone
May 10, 2021
May 10, 2021
WASHINGTON, May 10 -- Rep. Ayanna Pressley, D-Massachusetts, issued the following joint statement with Rep. Carolyn B. Maloney, D-New York:
* * *
Congresswoman Ayanna Pressley (MA-07), Chair of the Pro-Choice Caucus's Abortion Rights and Access Task Force, and House Oversight Committee Chairwoman Carolyn B. Maloney, issued the following statement in response to the Food and Drug Administration (FDA) announcing an evidence-based review of the in-person dispensing require . . .
* * *
Congresswoman Ayanna Pressley (MA-07), Chair of the Pro-Choice Caucus's Abortion Rights and Access Task Force, and House Oversight Committee Chairwoman Carolyn B. Maloney, issued the following statement in response to the Food and Drug Administration (FDA) announcing an evidence-based review of the in-person dispensing require . . .